Federal prosecutors, after a lengthy probe, are nearing possible criminal charges for price-collusion in the generic-drug industry, according to a person familiar with the matter. The U.S. Justice Department could begin to bring cases before year’s end, though the timing of any potential enforcement actions remains uncertain, according to the person familiar with the matter. The specific companies that are a focus of the...

Source: Wall Street Journal November 03, 2016 21:38 UTC